The traditional Chinese medicine industry has ushered in a period of opportunity, and a large number of enterprises will benefit

With the establishment and improvement of industry standards, mechanisms and service systems, the traditional Chinese medicine industry has begun to present a good situation of equal emphasis on traditional Chinese and Western medicine, support and regulation, inheritance and innovation, and the industry has gradually entered a stage of high-quality development
.
Among them, it is worth mentioning that in the aspect of new Chinese medicines, there is continuous good news
.
The traditional Chinese medicine industry has ushered in a period of opportunity (Photo source: Pharmaceutical Network) It is reported that in recent years, with the significant acceleration of the evaluation of new traditional Chinese medicines, statistics show that from 2016 to 2020, 13 new traditional Chinese medicines have been approved for marketing, and in 2021 In 2018, 12 new Chinese medicines were launched, setting a new high in the number of approvals in the past five years
.
At present, entering 2022, the innovation vitality of traditional Chinese medicine is still being released
.
Industry analysts believe that policy is the main positive factor for the development of the Chinese medicine industry
.
For example, since 2021, the release of policies such as "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine Characteristics" has brought dividends to the traditional Chinese medicine industry
.
And not only at the national level, but local governments are also frequently introducing new policies to support the development of traditional Chinese medicine
.
The industry expects that in the next few years, benefiting from the successive implementation of favorable policies in the Chinese medicine sector, the Chinese medicine industry will usher in a period of development opportunities
.
In this context, a large number of enterprises in the industrial chain will also benefit
.
Taking traditional Chinese medicine enterprises as an example, under the influence of a series of favorable policies, the pace of development of traditional Chinese medicine will be further accelerated in the future, and the market size will also show a trend of steady growth
.
At the same time, a large number of related companies are expected to usher in a huge market development space through continuous inheritance of essence, integrity and innovation.
At the same time, innovative research and development achievements will also continue to emerge, further enhancing their competitiveness
.
The author learned that under the background of the broad prospects of the traditional Chinese medicine industry, some pharmaceutical companies on the track have already made some new moves
.
For example, large-scale traditional Chinese medicine companies such as Buchang Pharmaceutical are actively deploying high-tech pharmaceuticals and striving to empower traditional Chinese medicine with modern technology
.
It is reported that in a public occasion at the end of 2021, Buchang Pharmaceutical has revealed that the company will continue to vigorously promote the building of traditional Chinese medicine brands in the future and promote traditional Chinese medicine to the world.

.
In addition, on January 7 this year, Liuyao Co.
, Ltd.
also stated when replying to investors on the interactive platform that the company will continue to increase investment in the layout of the traditional Chinese medicine sector, continue to improve its technical capabilities in the field of traditional Chinese medicine decoction pieces, and promote the digital upgrade of the industry.
, launched a traditional Chinese medicine traceability platform, and carried out related patent application and implementation applications such as identification, processing, and production of traditional Chinese medicine.
.
.
Of course, in addition to traditional Chinese medicine companies, the industry believes that the traditional Chinese medicine equipment industry will also usher in new opportunities
.
It is understood that the current demand for high-efficiency, energy-saving, low-carbon, environmentally friendly, automated and intelligent Chinese medicine pharmaceutical equipment in the traditional Chinese medicine industry is growing and improving
.
Therefore, the industry expects that pharmaceutical machine companies that have been actively deployed in these areas are expected to gain more opportunities for development
.
Among them, especially the equipment enabled by digitalization, it is expected to help the production of traditional Chinese medicine to start the journey of "intelligent manufacturing", and promote the accelerated transformation and upgrading of the industry
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.